Kratom, Once Again
Does this remind anyone of the 'grass roots' movement that arose to lobby Congress for reduced restriction on long-term opioid prescribing for chronic pain patients?
Select Page
Alcohol may be the oldest. New ones are being invented every day. There are thousands, and keeping track of what they are and what they do isn’t easy.
by C. Scott McMillin | Mar 18, 2024 | Addictive Substances | 0 |
Does this remind anyone of the 'grass roots' movement that arose to lobby Congress for reduced restriction on long-term opioid prescribing for chronic pain patients?
by C. Scott McMillin | Mar 14, 2024 | Recovery | 0 |
by C. Scott McMillin | Feb 29, 2024 | Addiction | 0 |
by C. Scott McMillin | Feb 22, 2024 | Addiction | 0 |
by C. Scott McMillin | Feb 15, 2024 | Addiction | 0 |
by C. Scott McMillin | Feb 8, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Feb 1, 2024 | Recovery | 0 |
The fact is, about a third of US adults don’t drink at all, or they drink so occasionally as to qualify as nondrinkers. I’ve noticed how difficult it can be for some patients in addiction treatment to believe that.
Read Moreby C. Scott McMillin | Jan 29, 2024 | Addictive Substances | 0 |
California State government has realized that these labs are essentially willing to fudge their results in order to please their customers in the cannabis industry.
Read Moreby C. Scott McMillin | Jan 25, 2024 | Addictive Substances | 0 |
Presumably, a licensed facilitator would be required to sign a code of ethical conduct, and would be subject to suspension or loss of license in the event they were found guilty of misbehavior.
Read Moreby C. Scott McMillin | Jan 18, 2024 | Addictive Substances | 0 |
Consumers may inadvertently find themselves addicted to tianeptine and should avoid all products containing tianeptine, especially those claiming to treat opioid use disorder.
Read Moreby C. Scott McMillin | Jan 15, 2024 | Treatment | 0 |
They found no clear correlation between cannabis use and a lessening of opioid dependence.
Read Moreby C. Scott McMillin | Jan 8, 2024 | Addictive Substances | 0 |
And for nitazenes, ‘ultra potent’ likely translates to ten or more times as powerful as fentanyl. Many hundreds of times beyond morphine.
Read Moreby C. Scott McMillin | Jan 4, 2024 | Addiction | 0 |
In that environment, alcohol abuse, no matter how excessive, was somehow acceptable. Normalized is the word for it.
Read Moreby C. Scott McMillin | Jan 1, 2024 | Addiction, Public Policy | 0 |
You’d have to be blind not to see the potential for serious problems, especially when you’re talking about high school and college-age students.
Read Moreby C. Scott McMillin | Dec 21, 2023 | Addictive Substances | 0 |
What seemed so incredibly important while under the influence had lost a lot of its charm when sober.
Read Moreby C. Scott McMillin | Dec 18, 2023 | Treatment | 0 |
Simply bringing up the possibility of ‘doing without’ could be immensely threatening.
Read Moreby C. Scott McMillin | Dec 14, 2023 | Addictive Substances, Public Policy | 0 |
It’s just good business. The stuff is virtually unregulated, far more affordable to make and distribute, and quite profitable, especially where conservative legislators are unlikely to legalize marijuana anytime soon.
Read Moreby C. Scott McMillin | Dec 11, 2023 | Addictive Substances | 0 |
P2P has two advantages over traditional ephedrine-based meth, from the perspective of a cartel. First, as a true synthetic, there’s no natural upper limit on how much can be produced. Second, the P2P form is extremely cheap, both to make and sell.
Read More